In a monumental victory for women’s health and scientific integrity, the Trump Administration has taken decisive action to end two decades of government-mandated misinformation. Health and Human Services Secretary Robert F. Kennedy Jr., in a powerful announcement, revealed that the Food and Drug Administration (FDA) will finally remove the misleading and fear-inducing “black box” warnings from hormone replacement therapy (HRT) medications.
These warnings, hastily implemented in 2003 based on a flawed and widely misinterpreted 2002 study from the Women’s Health Initiative, unnecessarily terrified an entire generation of women. For over twenty years, millions of American women were wrongly led to believe that HRT could significantly increase their risk of breast cancer and heart disease, scaring them away from a treatment that could have dramatically improved their quality of life during menopause.
Secretary Kennedy, flanked by FDA Commissioner Dr. Marty Makary, Second Lady Usha Vance, and Labor Secretary Lori Chavez-DeRemer, delivered a blistering indictment of the previous failed policies. He declared that the administration’s decision “restores integrity to medicine and faith in public health.” Kennedy did not mince words in describing the decades of neglect, stating, “For more than two decades, the American medical establishment turned its back on women. Millions of women were told to fear the very therapy that could have given them strength, peace, and dignity through one of life’s most difficult transitions—menopause. That ends today.”
The Secretary meticulously detailed how a single, statistically insignificant study triggered a media frenzy and a catastrophic overreaction by federal bureaucrats. “The label was designed to frighten women and to silence doctors,” Kennedy asserted. “It warned of diseases and dangers that the data simply did not support.” He highlighted the devastating consequences of this government-sponsored fearmongering, noting that HRT usage plummeted from one in four women to fewer than one in twenty, a decline he rightly labeled as “neglect” and “malpractice.”
In stark contrast to the fear-based decision-making of the past, this administration is championing a bold, evidence-based approach. Secretary Kennedy outlined the profound benefits of HRT that have been obscured for a generation, revealing that when started early, it “has been found to reduce the risk of cardiovascular disease and mortality by as much as 50%, Alzheimer’s disease by 35%, bone fractures by 50–60%, as well as reducing cognitive decline and all-cause mortality. In other words, extending lives by as much as ten years.”
RFK Jr. has announced that the FDA will remove the black box warnings from hormone replacement therapy for women — ending decades of medical neglect.
“For more than two decades, the American medical establishment turned its back on women.”
“We’re challenging outdated thinking… pic.twitter.com/J60lbWxR4j
— MAHA Action (@MAHA_Action) November 10, 2025
This historic correction would not have been possible without the unwavering leadership of President Donald J. Trump, who has consistently prioritized dismantling burdensome regulations and restoring common sense to the federal government. “But today, thanks to President Trump’s bold leadership and unwavering commitment to restoring trust in public health… the FDA is correcting that mistake,” Kennedy proclaimed. He emphatically declared that “the era of ignoring women’s health is over. The era of patronizing women is over.”
The FDA’s action, which follows a comprehensive scientific review, will empower women and their doctors to make informed decisions based on fact, not fear. This move is complemented by the approval of a long-awaited generic version of Premarin to increase affordability and a new non-hormonal treatment option, providing women with more choices than ever before.
h/t: Steadfast and Loyal
